Product Information

CARVEDILOL 6.25 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0175 per EA under NDC 65862014301. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Sep 5, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CARVEDILOL 6.25 MG TABLET

Carvedilol
$0.0175per EA

Strength

6.25 mg/1

NDC

65862014301

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

CARVEDILOL

Approval Type

Generic (ANDA)

FDA Application

ANDA078332

FDA Approved

9/5/2007

TE Code

AB

On Market Since

9/5/2007

Pharmacological Classes

Adrenergic alpha-Antagonists
Adrenergic beta1-Antagonists
Adrenergic beta2-Antagonists
alpha-Adrenergic Blocker
beta-Adrenergic Blocker

Price Statistics

The NADAC for CARVEDILOL 6.25 MG TABLET has been published 678 times since Nov 28, 2013, and over the history we have for it it has declined 45.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0175 per EA
All-time high$0.0350 (Jan 13, 2016)
All-time low$0.0155 (Nov 20, 2024)
52-week high$0.0187
52-week low$0.0175
Median price$0.0241
Average price$0.0240
Largest weekly change-21.2% (Nov 20, 2024)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

-0.3%

1M

-2.2%

3M

-3.0%

6M

-6.0%

1Y

-6.3%

3Y

-10.8%

5Y

-19.9%

All

-45.5%

Generic Alternatives

The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CARVEDILOL 6.25 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CARVEDILOL 6.25 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0175 per EA (NDC 65862014301), effective Nov 18, 2026.

How has the price of CARVEDILOL 6.25 MG TABLET changed over time?

Over the history we have for it, the NADAC for CARVEDILOL 6.25 MG TABLET has declined 45.5%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CARVEDILOL 6.25 MG TABLET?

Since Nov 28, 2013, the NADAC for CARVEDILOL 6.25 MG TABLET has ranged from a low of $0.0155 (Nov 20, 2024) to a high of $0.0350 (Jan 13, 2016), with a median of $0.0241 per EA.

Are there cheaper alternatives to CARVEDILOL 6.25 MG TABLET?

11 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CARVEDILOL 6.25 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures CARVEDILOL 6.25 MG TABLET?

CARVEDILOL 6.25 MG TABLET (NDC 65862014301) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.